Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological malignancies
靶向 CD161 抑制性受体可增强 T 细胞介导的抗血液系统恶性肿瘤免疫力。
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2023022882
Alvarez Calderon, Francesca; Kang, Byong H; Kyrysyuk, Oleksandr; Zheng, Shiwei; Wang, Hao; Mathewson, Nathan D; Luoma, Adrienne M; Ning, Xiaohan; Pyrdol, Jason; Cao, Xuan; Suvà, Mario L; Yuan, Guo-Cheng; Wittrup, K Dane; Wucherpfennig, Kai W
CD16
肿瘤
CD161
T细胞
肿瘤免疫
信号转导
细胞生物学
免疫/内分泌